PT  - JOURNAL ARTICLE
ED  - ,
TI  - Use of anticoagulants in pregnancy
AID  - 10.1136/dtb.25.1.1
DP  - 1987 Jan 12
TA  - Drug and Therapeutics Bulletin
PG  - 1--4
VI  - 25
IP  - 1
4099  - http://dtb.bmj.com/content/25/1/1.short
4100  - http://dtb.bmj.com/content/25/1/1.full
SO  - Drug Ther Bull1987 Jan 12; 25
AB  - Thromboembolic disease affects between 1 and 3 of every 1000 pregnant women.1 It is the second commonest cause of maternal death after hypertensive disease. Prevention and treatment with anticoagulants poses special problems because of the increase in coagulability and decrease in fibrinolysis during pregnancy and because of the increased risks to mother and fetus.2 Optimal procedures are far from agreed but the management of individual patients will be improved if obstetrician, general practitioner and haematologist work together to an agreed treatment plan. This article discusses how best to use anticoagulants in the management of thromboembolic disease in pregnancy.